Impact of Warfarin Persistence on Health-Care Utilization and Costs Among Patients With Atrial Fibrillation Managed in Anticoagulation Clinics in the United States

Podobne knjige/članki

• All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
  od: Deitelzweig, Steve, et al.
  Izdano: (2018)
• Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks
  od: Deitelzweig, Steve, et al.
  Izdano: (2013)
• Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States
  od: Deitelzweig, Steven, et al.
  Izdano: (2018)
• Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States
  od: Baker, Christine L., et al.
  Izdano: (2018)
• Warfarin Utilization and Anticoagulation Control in Patients with Atrial Fibrillation and Chronic Kidney Disease
  od: Yang, Felix, et al.
  Izdano: (2016)